In Depth 21 Apr 2023

Gut microbiome: a promising target for Parkinson’s

Parkinson’s cure ‘inevitable’ after biomarker breakthrough

In Depth 11 Apr 2023

Is a vaccine for Parkinson’s disease possible?

Neuron23 and QIAGEN to collaborate on diagnostic for novel Parkinson’s drug


Parkinson’s Foundation and Parkinson’s UK partner to drive drug development

Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech

Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s

New Gene Therapy for Parkinson’s will be Developed in the UK

German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s

Scottish Scientists Could Hold the Key to Unlocking Parkinson’s Disease